BioPharmGuy logo
Sponsored By:
Trianni Inc.
BioPharmGuy Database
Emery Pharma
Systagenix is defunct.

Fate: Acquired by KCI, Oct 2013, $485M


------------------
If you believe any of this information is incorrect, please let us know.